Showing results (1521-1530 of 5,510) with videos related to
Sort By:
Pageof 551
Theranostics|August 2, 2021
Twist1 contributes to developing and sustaining corticosteroid resistance in ulcerative colitisChangqin Liu, Li-Hua Mo, Bai-Sui Feng, et al.Theranostics|August 2, 2021
MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6PaseHui Zheng, Jian Wan, Yi Shan, et al.Theranostics|August 2, 2021
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagyAnna Mukha, Uğur Kahya, Annett Linge, et al.Theranostics|August 2, 2021
A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastomaJulie Bolcaen, Janke Kleynhans, Shankari Nair, et al.Theranostics|August 2, 2021
Emerging role of circulating tumor cells in immunotherapyAlexey Rzhevskiy, Alina Kapitannikova, Polina Malinina, et al.Theranostics|August 2, 2021
Endothelial cell infection and dysfunction, immune activation in severe COVID-19Zhongnan Qin, Fengming Liu, Robert Blair, et al.Theranostics|April 21, 2020
Size profile of cell-free DNA: A beacon guiding the practice and innovation of clinical testingJiping Shi, Runling Zhang, Jinming Li, et al.Theranostics|April 21, 2020
Radiation-induced small extracellular vesicles as "carriages" promote tumor antigen release and trigger antitumor immunityWanzun Lin, Yanyan Xu, Xiaochuan Chen, et al.Theranostics|April 21, 2020
Combination therapy with ropivacaine-loaded liposomes and nutrient deprivation for simultaneous cancer therapy and cancer pain reliefJiqian Zhang, Shasha Zhu, Qilian Tan, et al.Theranostics|April 21, 2020
Metastatic extent predicts survival as patients with metastatic castration-resistant prostate cancer are treated with <sup>177</sup>Lu-PSMA radioligand therapyFinn Edler von Eyben, Harshad R Kulkarni, Richard P BaumPageof 551